SCHEMBL5117814

SCHEMBL5117814

O=C(CC(=O)C(F)(F)F)c1cc(F)ccc1F

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLOD2 O00469 3/20 0.59
CES2 O00748 3/20 0.53
CES1 P23141 3/20 0.53
PLOD3 O60568 2/20 0.45
PLOD1 Q02809 2/20 0.45
MAPT P10636 2/20 0.41
ALDH1A1 P00352 1/20 0.41
MDM2 Q00987 3/20 0.38
PTPN1 P18031 1/20 0.38
ERCC5 P28715 1/20 0.38
FEN1 P39748 1/20 0.38
POLB P06746 1/20 0.37
P2RX1 P51575 1/20 0.37
TMPRSS4 Q9NRS4 1/20 0.37
KEAP1 Q14145 1/20 0.37
TAS1R3 Q7RTX0 1/20 0.37
TAS1R1 Q7RTX1 1/20 0.37
TAS1R2 Q8TE23 1/20 0.37
DRD2 P14416 1/20 0.36
PSMB11 A5LHX3 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4599561 0.87 CES2 (0.50) PLOD2CES2CES1MAPTALDH1A1
SCHEMBL1924321 0.86 PLOD2 (0.59) PLOD2CES2CES1PLOD3PLOD1
SCHEMBL1924959 0.79 PTPN1 (0.61) PLOD2CES2CES1PLOD3PLOD1
SCHEMBL25204030 0.76 CES2 (0.53) CES2CES1MAPTALDH1A1MDM2
SCHEMBL21509855 0.76 CES2 (0.63) CES2CES1MAPTALDH1A1MDM2
SCHEMBL27764538 0.76 CES2 (0.63) CES2CES1MAPTALDH1A1MDM2
SCHEMBL4615347 0.75 PLOD2 (0.45) PLOD2PLOD3PLOD1MAPTALDH1A1
Trifluoroacetic Acid SCHEMBL2295710 0.74 CES2 (0.47) CES2CES1MAPTALDH1A1MDM2
SCHEMBL8639619 0.74 PLOD2 (0.46) PLOD2CES2CES1MAPTALDH1A1
SCHEMBL15435529 0.74 CES2 (0.61) CES2CES1MAPTALDH1A1MDM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0791571-A1 Benzoyl derivatives MONSANTO COMPANY (US) 1997-08-27 EP claimed
US-20080214642-A1 Fungicidal N-Benzyl-5-Hydroxy-5-Phenylpryrazolines, Processes For Their Preparation and Compositions Comprising Them BASF AKTIENGESELLSCHAFT (DE) 2008-09-04 US disclosed
EP-0791571-B1 Benzoyl derivatives BAYER CROPSCIENCE AG (DE) 2004-06-16 EP disclosed
EP-0553307-B1 HERBICIDAL SUBSTITUTED ARYL-HALOALKYLPYRAZOLES MONSANTO CO (US) 1998-12-09 EP disclosed
EP-0791571-A1 Benzoyl derivatives MONSANTO COMPANY (US) 1997-08-27 EP disclosed
US-5536700-A Herbicidal compositions comprising aryl-5-haloalkylpyrazoles and glyphosate, it's salts, diquat or paraquat MONSANTO COMPANY (US) 1996-07-16 US disclosed
US-5530126-A ALKYLATION IN INERT SOLVENT MONSANTO COMPANY (US) 1996-06-25 US disclosed
US-5496956-A BY ESTERIFICATION OF CARBOXY SUBSTITUTION WITH ALCOHOLS IN THE PRESENCE OF MINERAL ACID MONSANTO COMPANY (US) 1996-03-05 US disclosed
US-5489571-A CROP-SAFE COMPOUNDS EFFECTIVE AT LOW CONCENTRATIONS MONSANTO COMPANY (US) 1996-02-06 US disclosed
US-5281571-A Herbicidal benzoxazinone- and benzothiazinone-substituted pyrazoles MONSANTO COMPANY (US) 1994-01-25 US disclosed
EP-0553307-A1 HERBICIDAL SUBSTITUTED ARYL-HALOALKYLPYRAZOLES MONSANTO COMPANY (US) 1993-08-04 EP disclosed
WO-1992006962-A1 HERBICIDAL SUBSTITUTED ARYL-HALOALKYLPYRAZOLES MONSANTO COMPANY (US) 1992-04-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080214642-A1 Fungicidal N-Benzyl-5-Hydroxy-5-Phenylpryrazolines, Processes For Their Preparation and Compositions Comprising Them CBR3, CBR1, CYP4X1 PLOD2 692/4885CES2 212/4885CES1 676/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.